Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04858256
Title Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Indications

peripheral T-cell lymphoma

primary cutaneous T-cell non-Hodgkin lymphoma

Therapies

Pacritinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.